Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 22,076 | 17,451 | 10,052 | 18,951 | 14,287 |
| Cost of Goods | 6,160 | 3,860 | 2,990 | 8,710 | 6,770 |
| Gross Profit | 15,910 | 13,590 | 7,060 | 10,910 | 7,510 |
| Operating Expenses | 13,050 | 12,300 | 10,240 | 14,320 | 12,950 |
| Operating Income | 3,026 | 2,151 | -2,188 | -3,369 | -4,663 |
| Interest Expense | 730 | 770 | 660 | 30 | 300 |
| Other Income | 644 | 509 | 488 | -2,651 | 1,093 |
| Pre-tax Income | 2,940 | 1,890 | -2,360 | -6,050 | -3,870 |
| Income Tax | 70 | -10 | 2 | -93 | 6 |
| Net Income Continuous | 2,309 | 1,914 | -2,008 | -5,434 | -3,002 |
| Net Income | $2,309 | $1,914 | $-2,008 | $-5,434 | $-3,002 |
| EPS Basic Total Ops | 0.04 | 0.02 | -0.04 | -0.10 | -0.06 |
| EPS Basic Continuous Ops | 0.04 | 0.03 | -0.04 | -0.10 | -0.05 |
| EPS Diluted Total Ops | 0.04 | 0.02 | -0.04 | -0.10 | -0.05 |
| EPS Diluted Continuous Ops | 0.04 | 0.03 | -0.04 | -0.10 | -0.05 |
| EBITDA(a) | $4,676 | $3,941 | $-498 | $1,111 | $-7,213 |